Status:
RECRUITING
Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Giant Cell Arteritis
Eligibility:
All Genders
50+ years
Brief Summary
Giant cell arteritis (GCA), also known as Horton's disease, is an inflammatory arteritis of the large and medium-sized arteries, with an estimated incidence of 17.8/100,000 in people over 50. The dis...
Eligibility Criteria
Inclusion
- Patient aged 50 and over
- Having received informed consent to participate in the study
- Affiliated or beneficiary of a social insurance scheme
- Patients with giant cell arteritis according to ACR/EULAR 2022 criteria
- Diagnosed with MRI and ultrasound.
Exclusion
- Absolute or relative contraindication to MRI (incompatible implantable device, claustrophobia, etc.)
- Hypersensitivity to gadobutrol
- Patient under legal protection
- Pregnant or breast-feeding women
Key Trial Info
Start Date :
November 28 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06004154
Start Date
November 28 2023
End Date
April 1 2027
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Fondation Adolphe de Rothschild
Paris, France, 75019